Low-dose Cortisol in Chronic Posttraumatic Stress Disorder
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The aim of this prospective, double-blind, placebo-controlled, cross-over study is to
determine the therapeutic efficacy of low-dose cortisol for symptoms of chronic posttraumatic
stress disorder.